SBIO Holdings Information

SBIO is an equity ETF with a total of 107 individual holdings. The top holdings are Rhythm Pharmaceuticals stock at 3.46%, Nuvalent at 3.38%, Axsome Therapeutics at 3.38%, Alkermes at 3.14%, and Vaxcyte at 2.92%.

Total Holdings

107

Top 10 Percentage

29.47%

Asset Class

Equity

ETF Category

Health

Assets

77.95M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

As of Jul 11, 2025

No.	Symbol	Name	% Weight	Shares
1	RYTM	Rhythm Pharmaceuticals, Inc.	3.46%	30,938
2	NUVL	Nuvalent, Inc.	3.38%	32,402
3	AXSM	Axsome Therapeutics, Inc.	3.38%	24,032
4	ALKS	Alkermes plc	3.14%	80,519
5	PCVX	Vaxcyte, Inc.	2.92%	63,054
6	CYTK	Cytokinetics, Incorporated	2.78%	58,312
7	KRYS	Krystal Biotech, Inc.	2.68%	14,048
8	MTSR	Metsera, Inc.	2.60%	51,326
9	AKRO	Akero Therapeutics, Inc.	2.58%	38,869
10	MRUS	Merus N.V.	2.55%	36,335
11	PTCT	PTC Therapeutics, Inc.	2.42%	38,679
12	ACLX	Arcellx, Inc.	2.39%	26,860
13	RNA	Avidity Biosciences, Inc.	2.39%	58,894
14	ZLAB	Zai Lab Limited	2.32%	55,068
15	ACAD	ACADIA Pharmaceuticals Inc.	2.21%	81,739
16	VKTX	Viking Therapeutics, Inc.	2.20%	54,919
17	PTGX	Protagonist Therapeutics, Inc.	2.06%	30,208
18	MLTX	MoonLake Immunotherapeutics	1.96%	31,060
19	CRNX	Crinetics Pharmaceuticals, Inc.	1.88%	45,754
20	MIRM	Mirum Pharmaceuticals, Inc.	1.64%	24,116
21	ARWR	Arrowhead Pharmaceuticals, Inc.	1.59%	67,467
22	XENE	Xenon Pharmaceuticals Inc.	1.56%	37,480
23	APLS	Apellis Pharmaceuticals, Inc.	1.54%	61,371
24	NAMS	NewAmsterdam Pharma Company N.V.	1.52%	54,841
25	AGIO	Agios Pharmaceuticals, Inc.	1.43%	28,324

As of Jul 11, 2025

Showing 25 of 107

Subscribe to see the full list